Lyra Therapeutics (LYRA) Research & Development (2021 - 2025)
Historic Research & Development for Lyra Therapeutics (LYRA) over the last 5 years, with Q3 2025 value amounting to $4.0 million.
- Lyra Therapeutics' Research & Development fell 3143.0% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.4 million, marking a year-over-year decrease of 5893.9%. This contributed to the annual value of $43.8 million for FY2024, which is 887.59% down from last year.
- According to the latest figures from Q3 2025, Lyra Therapeutics' Research & Development is $4.0 million, which was down 3143.0% from $5.1 million recorded in Q2 2025.
- Over the past 5 years, Lyra Therapeutics' Research & Development peaked at $18.2 million during Q1 2024, and registered a low of $4.0 million during Q3 2025.
- For the 5-year period, Lyra Therapeutics' Research & Development averaged around $9.2 million, with its median value being $9.5 million (2022).
- As far as peak fluctuations go, Lyra Therapeutics' Research & Development soared by 7830.19% in 2022, and later tumbled by 7326.46% in 2025.
- Over the past 5 years, Lyra Therapeutics' Research & Development (Quarter) stood at $10.3 million in 2021, then fell by 8.62% to $9.5 million in 2022, then rose by 29.79% to $12.3 million in 2023, then plummeted by 48.13% to $6.4 million in 2024, then plummeted by 36.39% to $4.0 million in 2025.
- Its Research & Development was $4.0 million in Q3 2025, compared to $5.1 million in Q2 2025 and $4.9 million in Q1 2025.